Evidence map›Paper›PMID 37669408›Full record

ArticleACS nano2023

Exploring the Landscape of the PP7 Virus-like Particle for Peptide Display.

Parisa Keshavarz-Joud, Liangjun Zhao, Daija Bobe, Carolina Hernandez, Mykhailo Kopylov, Laura Y Yen, Naima Djeddar, Brianna Thompson, Caleb Connors, Greg Gibson and 2 more

Open access · hybridAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pleomorphism in Wild-Type and Engineered PP7 Virus-Like Particles.Small (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Parisa Keshavarz-JoudSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
Liangjun ZhaoSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.ORCID 0000-0002-0792-1473
Daija BobeNew York Structural Biology Center, New York, New York 10027, United States.
Carolina HernandezNew York Structural Biology Center, New York, New York 10027, United States.
Mykhailo KopylovNew York Structural Biology Center, New York, New York 10027, United States.
Laura Y YenNew York Structural Biology Center, New York, New York 10027, United States.
Naima DjeddarParker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
Brianna ThompsonSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
Caleb ConnorsSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
Greg GibsonSchool of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
Anton BryksinParker H. Petit Institute for Bioengineering and Biosciences, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.
M G FinnSchool of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, Georgia 30306, United States.ORCID 0000-0001-8247-3108
Georgia Institute of Technology · USNew York Structural Biology Center · US

Funding

Virus-Like Particle Based Immunization Against Peanut AllergyR21AI166639 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI FINN, M.G. · 2021 to 2022
$450k
NIAID NIH HHS R21 AI166639
6 · The paper itself

Abstract

Self-assembling virus-like particles (VLPs) can tolerate a wide degree of genetic and chemical manipulation to their capsid protein to display a foreign molecule polyvalently. We previously reported the successful incorporation of foreign peptide sequences in the junction loop and onto the C-terminus of PP7 dimer VLPs, as these regions are accessible for surface display on assembled capsids. Here, we report the implementation of a library-based approach to test the assembly tolerance of PP7 dimer capsid proteins to insertions or terminal extensions of randomized 15-mer peptide sequences. By performing two iterative rounds of assembly-based selection, we evaluated the degree of favorability of all 20 amino acids at each of the 15 randomized positions. Deep sequencing analysis revealed a distinct preference for the inclusion of hydrophilic peptides and negatively charged amino acids (Asp and Glu) and the exclusion of positively charged peptides and bulky and hydrophobic amino acid residues (Trp, Phe, Tyr, and Cys). Within the libraries tested here, we identified 4000 to 22,000 unique 15-mer peptide sequences that can successfully be displayed on the surface of the PP7 dimer capsid. Overall, the use of small initial libraries consisting of no more than a few million members yielded a significantly larger number of unique and assembly-competent VLP sequences than have been previously characterized for this class of nucleoprotein particle.

Indexed as

Amino AcidsPeptidesAmino Acid SequenceCapsidCapsid ProteinsPolymersAmino AcidsCapsid ProteinsPeptidesPolymersmolecular librarypeptide displayselectionself-assemblyvirus-like particles

Identifiers

PMID37669408
PMCPMC10540251
OpenAlexW4386453209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.